ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,955 | -8.8% | 970,151 | 0.0% | 1.76% | +3.2% |
| Q4 2022 | $38,340 | -99.9% | 970,151 | 0.0% | 1.70% | -7.8% |
| Q3 2022 | $38,981,000 | -4.4% | 970,151 | 0.0% | 1.85% | +5.1% |
| Q2 2022 | $40,785,000 | +7.9% | 970,151 | 0.0% | 1.76% | +8.5% |
| Q1 2022 | $37,797,000 | -2.2% | 970,151 | 0.0% | 1.62% | -5.3% |
| Q4 2021 | $38,661,000 | +10.3% | 970,151 | 0.0% | 1.71% | +3.7% |
| Q3 2021 | $35,061,000 | -11.8% | 970,151 | 0.0% | 1.65% | -9.7% |
| Q2 2021 | $39,766,000 | -99.1% | 970,151 | 0.0% | 1.83% | -91.5% |
| Q1 2021 | $4,231,798,000 | +113.6% | 970,151 | -75.5% | 21.59% | -0.4% |
| Q4 2020 | $1,981,228,000 | +18.5% | 3,958,498 | -0.4% | 21.69% | +8.2% |
| Q3 2020 | $1,671,777,000 | -13.3% | 3,973,800 | 0.0% | 20.05% | -28.5% |
| Q2 2020 | $1,929,279,000 | – | 3,973,800 | – | 28.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |